PwC's Glenn Hunzinger stops by to discuss the  Pharmaceutical and life sciences deals insights: 2021 midyear outlook report, showcasing the PLS sector returned to normal deal activity with strong deal volume. Plus, Omar Ford, MD+DI's Managing Editor gives his take on the controversial Illumina/Grail merger.

David Perry, chairman and co-founder of Better Therapeutics, spoke with Let’s Talk Medtech about the company’s efforts and going public through a Special Purpose Acquisition Corporation Merger (SPAC).

Dexcom's Kevin Sayer discusses the company's studies from ADA, the future of continuous glucose monitoring and gives an update to the G7 device.

A discussion about Medtronic’s CareLink SmartSync Device Manager, the MD+DI Readers' Choice winner in the 2021 Medical Design Excellence Awards

Talking ECG monitoring with Cardiac Insight's David Haley, Phd

Leaders from Neurolutions guest star on this episode of Let's Talk Medtech to take us behind the design and engineering of the IpsiHand System, an exoskeleton that uses a brain-computer interface platform to facilitate muscle re-education for stroke victims.

John Sperzel, CEO of T2 Biosystems, stops by Let's Talk Medtech to chat about his newly published book, "Courage: Powerful Lessons in Leadership, Strength, and the Will to Succeed."

A discussion with Asensus Surgical's CEO Anthony Fernando.

A special look at ResMed's progress during the Pandemic and how the company incorporated software engineers into the fold.

In this episode of Let's Talk Medtech, Kevin Thornal, Hologic's Division President, Diagnostic Solutions, discusses with MD+DI Editor Daphne Allen the company's efforts to expand the reach of its diagnostics offerings as well as to address unmet needs in oncology and more. He also explains the company's slogan, "The Science of Sure," and why it is important to keep patient needs in mind every day. Hologic was MD+DI's 2020 Readers’ Choice Company of the Year.